Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adastra Labs is the Health Canada-licensed cannabis processing subsidiary associated with Adastra Holdings, a Canadian public company focused on extraction, distillation, formulation, and manufacturing of cannabis-derived products. The business operates a 13,500 sq. ft. facility in Langley, British Columbia and supports both branded and co-manufactured products for adult-use and medical cannabis markets. Its in-house brands include Phyto Extractions and Endgame Extracts, and the company has emphasized concentrates, extracts, topicals, edibles, and related cannabis formulations. Adastra also works alongside Chemia Analytics, its co-located analytical testing laboratory affiliate, and has described forward-looking ambitions in therapeutic and ethnobotanical applications. For a biotech analyst, this is best understood as a commercial cannabis processing and product manufacturing company rather than a traditional drug-development biotech with a clinical therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Adastra Labs.